Dr. Hwang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2799 W Grand Blvd
CFP5
Detroit, MI 48202Phone+1 313-916-2600Fax+1 313-916-7911
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 2005 - 2008
- University of MichiganResidency, Internal Medicine, 2001 - 2004
- University of Michigan Medical SchoolClass of 2001
Certifications & Licensure
- MI State Medical License 2001 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET Start of enrollment: 2019 Sep 21
Roles: Contact
- Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer Start of enrollment: 2024 Jun 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 27 citationsInterplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.Ziad Bakouny, Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati
JAMA Oncology. 2023-01-01 - 31 citationsClinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Cli...Ulka N. Vaishampayan, Lance K. Heilbrun, Paul Monk, Sheela Tejwani, Guru Sonpavde
JAMA Network Open. 2021-01-04 - 316 citationsPembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, ...Thomas Powles, Tibor Csőszi, Mustafa Ozguroglu, Nobuaki Matsubara, Lajos Géczi
The Lancet. Oncology. 2021-07-01
Press Mentions
- Closing the Cancer Disparities Gap Broadened by COVID-19November 10th, 2022
- Study of Cancer Patients and COVID-19 Highlights Health DisparitiesJuly 21st, 2021
- Antiandrogens Augment Growing Armamentarium in Metastatic Prostate CancerJanuary 3rd, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: